Schrader, Anne M. R. http://orcid.org/0000-0003-3483-0558
de Groen, Ruben A. L.
Willemze, Rein
Jansen, Patty M.
Quint, Koen D.
van Wezel, Tom
van Eijk, Ronald
Ruano, Dina
Tensen, Cornelis P.
Hauben, Esther
Woei-A-Jin, F. J. S. H.
Busschots, Anne M.
van den Berg, Anke
Diepstra, Arjan
Vermeer, Maarten H.
Vermaat, Joost S. P.
Article History
Received: 24 August 2021
Revised: 15 December 2021
Accepted: 28 December 2021
First Online: 14 January 2022
Declarations
:
: The study was performed in accordance with the Code Proper Secondary Use of Human Tissue and to the regulations of in-house Biobank protocol, as approved by the Medical Ethics Committee of the LUMC and the UZL.
: M.V. is a member of an entity’s Board of Directors or advisory committees of the Innate Pharma safety board for IPH4102-101. The remaining authors have no relevant financial or non-financial interest to disclose.